Conotruncal cardiac defects are malformations of the outflow tracts of the heart, which account for 16% of all congenital heart defects. Despite their clinical significance, their etiology is poorly understood. Studies indicate that the etiology of conotruncal defects is heterogeneous and complex, and includes both environmental and genetic factors. Because multiplex families amenable to parametric linkage analyses are extraordinarily rare, alternative approaches to identify genetic causes of these heart defects have been taken. Candidate genes and chromosomal loci have been identified through molecular analyses of genetic syndromes and from animal models. Epidemiologic studies have also suggested that the folate metabolic pathway may influence the risk of developing conotruncal defects. We have ascertained a large cohort of subjects with conotruncal cardiac defects and have identified mutations in a subset of patients in two key developmental genes: NKX2.5 and CFCI. Based on the literature and our preliminary studies, we hypothesize that three specific metabolic and developmental pathways contribute to the etiology of conotruncal defects including: (1) the folate-homocysteine metabolic axis, (2) NKX2.5 and its molecular partners, and (3) human disease genes (such as CFC1) associated with the abnormalities of left-right asymmetry. We propose to continue our efforts to define the genetic basis of conotruncal defects using family-based association studies and mutation analyses of candidate genes in these pathways. For genetic variants in the folate-homocysteine metabolic axis, novel family-based association studies will examine whether the maternal or embryonic genotype influences the risk of conotruncal defects. These studies will also begin to explore whether maternal-fetal genotype interactions, gene-gene interactions acting at the level of the mother or embryo, and gene-environment interactions influence conotruncal development. Developmental genes, such as those interacting with NKX2.5 or those participating in left-right asymmetry, will be studied for mutations and in select cases, for the influence of embryonic genotype on disease. The overall goal of this project is to further elucidate genetic factors that contribute to the etiology of conotruncal defects. With this data, the impact of genotype on clinical outcome can be assessed and improved management strategies devised for the future. ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL076773-03
Application #
7054115
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Schramm, Charlene A
Project Start
2004-08-15
Project End
2008-05-31
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
3
Fiscal Year
2006
Total Cost
$303,019
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Agopian, A J; Goldmuntz, Elizabeth; Hakonarson, Hakon et al. (2017) Genome-Wide Association Studies and Meta-Analyses for Congenital Heart Defects. Circ Cardiovasc Genet 10:e001449
Mercer-Rosa, Laura; Pinto, Nelangi; Yang, Wei et al. (2013) 22q11.2 Deletion syndrome is associated with perioperative outcome in tetralogy of Fallot. J Thorac Cardiovasc Surg 146:868-73
Goldmuntz, Elizabeth; Paluru, Prasuna; Glessner, Joseph et al. (2011) Microdeletions and microduplications in patients with congenital heart disease and multiple congenital anomalies. Congenit Heart Dis 6:592-602
Agopian, A J; Mitchell, Laura E (2011) MI-GWAS: a SAS platform for the analysis of inherited and maternal genetic effects in genome-wide association studies using log-linear models. BMC Bioinformatics 12:117
Long, Jin; Lupo, Philip J; Goldmuntz, Elizabeth et al. (2011) Evaluation of heterogeneity in the association between congenital heart defects and variants of folate metabolism genes: conotruncal and left-sided cardiac defects. Birth Defects Res A Clin Mol Teratol 91:879-84
Lupo, Philip J; Mitchell, Laura E; Goldmuntz, Elizabeth (2011) NAT1, NOS3, and TYMS genotypes and the risk of conotruncal cardiac defects. Birth Defects Res A Clin Mol Teratol 91:61-5
Lupo, Philip J; Goldmuntz, Elizabeth; Mitchell, Laura E (2010) Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects. J Biomed Biotechnol 2010:630940
Goldmuntz, Elizabeth; Woyciechowski, Stacy; Renstrom, Daniel et al. (2008) Variants of folate metabolism genes and the risk of conotruncal cardiac defects. Circ Cardiovasc Genet 1:126-32
Goldmuntz, Elizabeth (2004) The genetic contribution to congenital heart disease. Pediatr Clin North Am 51:1721-37, x